-
Study aim
-
Comparative study of the effect of nasal dexmedetomidine and oral chloral hydrate on pediatric sedation during electroencephalogram
-
Design
-
Clinical trial with control group with parallel groups, phase 2-3 on 64 patients
-
Settings and conduct
-
This study is performed in Imam Hossein Hospital in Isfahan. Patients will be treated with relaxation before the electroencephalogram in two ways. Data on heart rate, blood pressure, and sedation in patients are measured and compared.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: children 6 months to 6 years old, candidates for ECG for any reason, lack of proper cooperation for ECG, need to create sedation for ECG
Exclusion criteria: history of respiratory diseases, peptic ulcer, liver disease, presence of treatment with drugs that interact with chloral hydrate or dexmedetomidine, lack of written informed consent of parents for children to enter the study
-
Intervention groups
-
Intervention group 1: Patients in this group, before the intervention, recieve intranasal dexmedetomidine from Abu Reihan company with dosage of 2-3 micrograms per kilogram and 10 minutes before the procedure. Intervention group 2: Patients in this group will receive 5% chloral hydrate syrup at a dose of 50-100 mg per kg orally 10 minutes before the procedure before the intervention. Patients will be monitored by the Pediatric Anesthesia Fellowship during the electroencephalogram, and information about patients' heart rate, blood pressure before and during the procedure will be monitored and recorded every 5 minutes.For each patient, the sleep onset latency is also recorded.
-
Main outcome variables
-
Heart rate, blood pressure, sleep onset latency